Incoming Takeda CEO Julie Kim says the drugmaker “anticipated” this week’s selection of Entyvio for Medicare negotiations. But for now, the company isn’t ready to comment on how the process could affect peak revenue forecasts …
Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says
Takeda’s incoming CEO took a firm stance against President Donald Trump’s “most favored nation” deals with drugmakers on Thursday, while Sanofi and Roche shared new


